Tubulis has raised series A funding to progress an ADC development platform invented at Leibniz Research Institute and Ludwig Maximillians University.
Frontier IP attracted $2.9m in a placement that will support its portfolio in responding to coronavirus-related challenges or opportunities.
Tübingen's messenger RNA vaccine and drug developer's latest round includes a $171m investment by strategic partner GlaxoSmithKline.
Scalable Capital is valued in excess of $460m following a round that lifted the digital wealth manager's total funding to about $130m.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Boehringer Ingelheim Venture Fund followed an investment last September by contributing to a $26.8m round for the Basel spinout.